News of the WeekDIABETES RESEARCH

Researchers Puzzle Over Possible Effect of Gleevec

See allHide authors and affiliations

Science  18 Mar 2005:
Vol. 307, Issue 5716, pp. 1711
DOI: 10.1126/science.307.5716.1711a

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Can a targeted cancer drug help treat diabetes? That's a question two independent teams of Italians are asking after giving leukemia patients the drug Gleevec and watching their preexisting diabetes regress.